These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 9449486)
21. CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma. Awaya N; Mori S; Takeuchi H; Mori S; Sugano Y; Kamata T; Takeuchi T; Abe T Am J Hematol; 2002 Mar; 69(3):200-4. PubMed ID: 11891807 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of tyrosine kinase activity induces caspase-dependent apoptosis in anaplastic large cell lymphoma with NPM-ALK (p80) fusion protein. Ergin M; Denning MF; Izban KF; Amin HM; Martinez RL; Saeed S; Alkan S Exp Hematol; 2001 Sep; 29(9):1082-90. PubMed ID: 11532349 [TBL] [Abstract][Full Text] [Related]
23. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Shiota M; Nakamura S; Ichinohasama R; Abe M; Akagi T; Takeshita M; Mori N; Fujimoto J; Miyauchi J; Mikata A; Nanba K; Takami T; Yamabe H; Takano Y; Izumo T; Nagatani T; Mohri N; Nasu K; Satoh H; Katano H; Fujimoto J; Yamamoto T; Mori S Blood; 1995 Sep; 86(5):1954-60. PubMed ID: 7655022 [TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease. Yee HT; Ponzoni M; Merson A; Goldstein M; Scarpa A; Chilosi M; Menestrina F; Pittaluga S; de Wolf-Peeters C; Shiota M; Mori S; Frizzera G; Inghirami G Blood; 1996 Feb; 87(3):1081-8. PubMed ID: 8562933 [TBL] [Abstract][Full Text] [Related]
25. ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35). Colleoni GW; Bridge JA; Garicochea B; Liu J; Filippa DA; Ladanyi M Am J Pathol; 2000 Mar; 156(3):781-9. PubMed ID: 10702393 [TBL] [Abstract][Full Text] [Related]
26. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms. Sarris AH; Luthra R; Cabanillas F; Morris SW; Pugh WC Leuk Lymphoma; 1998 May; 29(5-6):507-14. PubMed ID: 9643564 [TBL] [Abstract][Full Text] [Related]
27. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Elmberger PG; Lozano MD; Weisenburger DD; Sanger W; Chan WC Blood; 1995 Nov; 86(9):3517-21. PubMed ID: 7579458 [TBL] [Abstract][Full Text] [Related]
28. The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation. Li G; Salhany KE; Rook AH; Lessin SR J Cutan Pathol; 1997 Aug; 24(7):403-8. PubMed ID: 9274957 [TBL] [Abstract][Full Text] [Related]
29. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Shiota M; Fujimoto J; Takenaga M; Satoh H; Ichinohasama R; Abe M; Nakano M; Yamamoto T; Mori S Blood; 1994 Dec; 84(11):3648-52. PubMed ID: 7949120 [TBL] [Abstract][Full Text] [Related]
30. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Maes B; Vanhentenrijk V; Wlodarska I; Cools J; Peeters B; Marynen P; de Wolf-Peeters C Am J Pathol; 2001 Jun; 158(6):2185-93. PubMed ID: 11395396 [TBL] [Abstract][Full Text] [Related]
31. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414 [TBL] [Abstract][Full Text] [Related]
32. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Shiota M; Mori S Leukemia; 1997 Apr; 11 Suppl 3():538-40. PubMed ID: 9209450 [TBL] [Abstract][Full Text] [Related]
33. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Lamant L; Dastugue N; Pulford K; Delsol G; Mariamé B Blood; 1999 May; 93(9):3088-95. PubMed ID: 10216106 [TBL] [Abstract][Full Text] [Related]
34. Expression of carbohydrate antigens, p80NPM/ALK, cytotoxic cell-associated antigens, and Epstein-Barr virus gene products in anaplastic large cell lymphomas. Kasai K; Kon S; Kikuchi K; Sato Y; Kameya T Pathol Int; 1998 Mar; 48(3):171-8. PubMed ID: 9589484 [TBL] [Abstract][Full Text] [Related]
36. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Benharroch D; Meguerian-Bedoyan Z; Lamant L; Amin C; Brugières L; Terrier-Lacombe MJ; Haralambieva E; Pulford K; Pileri S; Morris SW; Mason DY; Delsol G Blood; 1998 Mar; 91(6):2076-84. PubMed ID: 9490693 [TBL] [Abstract][Full Text] [Related]
37. A lymphohistiocytic variant of anaplastic large cell lymphoma with demonstration of the t(2;5)(p23;q35) chromosome translocation. Ott G; Bastian BC; Katzenberger T; Decoteau JF; Kalla J; Rosenwald A; Weissinger F; Ott MM; Kadin ME; Müller-Hermelink HK Br J Haematol; 1998 Jan; 100(1):187-90. PubMed ID: 9450809 [TBL] [Abstract][Full Text] [Related]
38. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631 [TBL] [Abstract][Full Text] [Related]
39. Molecular variant of the NPM-ALK rearrangement of Ki-1 lymphoma involving a cryptic ALK splice site. Ladanyi M; Cavalchire G Genes Chromosomes Cancer; 1996 Mar; 15(3):173-7. PubMed ID: 8721682 [TBL] [Abstract][Full Text] [Related]
40. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products. Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]